Form 4: Hims & Hers Health Chief Legal Officer Sells Shares Under 10b5-1 Plan

Soleil Boughton, Chief Legal Officer of Hims & Hers Health, sold 2,343 shares of Class A Common Stock at $29.9 per share on November 26, 2024, under a pre-arranged 10b5-1 trading plan.

Summary

• Soleil Boughton, the Chief Legal Officer of Hims & Hers Health, Inc., sold 2,343 shares of Class A Common Stock on November 26, 2024.
• The sale was executed at a price of $29.9 per share.
• This transaction was conducted under a pre-established Rule 10b5-1 trading plan adopted on September 10, 2023.
• Following the sale, Boughton directly owns 165,254 shares of Class A Common Stock.

Sentiment

Score: 5

Explanation: The document is a routine SEC filing related to an insider stock sale under a pre-arranged plan. It does not indicate any positive or negative sentiment.

Industry Context

This is a routine filing related to insider trading activity. It is common for executives to use 10b5-1 plans to sell shares to avoid accusations of insider trading.

Comparison to Industry Standards

• The use of 10b5-1 trading plans is a standard practice among corporate executives to manage their stock sales and avoid potential insider trading issues.
• Many companies have executives who use these plans to sell shares regularly, and this activity is not unusual.

Stakeholder Impact

• The sale of shares by a company executive may have a minor impact on shareholder sentiment, but it is unlikely to be significant given the pre-planned nature of the transaction.

Key Dates

Keywords

Form 4, Hims & Hers Health, insider trading, Rule 10b5-1, stock sale, Soleil Boughton, Chief Legal Officer